Lanzieri Tatiana M, Caviness A Chantal, Williams Jill J, Demmler-Harrison Gail
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
J Clin Virol. 2025 Feb;176:105756. doi: 10.1016/j.jcv.2024.105756. Epub 2024 Dec 3.
Cytomegalovirus (CMV) infection in children is associated with prolonged viral excretion in urine and saliva. This study characterizes CMV urinary excretion in children with congenital (cCMV) and postnatally acquired CMV infection.
Children with virologically confirmed cCMV (75 symptomatic and 105 asymptomatic at birth) and 51 children without cCMV were followed through median 11, 18 and 17 years of age, respectively. In children with cCMV, duration of CMV excretion was defined as uninterrupted positive results from initial to last positive culture, and recurrent CMV excretion as ≥1 positive following >1 negative result. CMV urinary excretion in children without cCMV was defined as resulting from postnatally acquired CMV infection.
Mean duration of persistent CMV urinary excretion in children with cCMV was 1.9 (maximum 8.7) years for symptomatic and 2.8 (maximum 9.8) years for asymptomatic children (P = 0.011). Mean duration of CMV excretion was not statistically different for 17 symptomatic children treated with ganciclovir (2.4 years) compared with 58 untreated (1.8 years); P = 0.356. Recurrent excretion occurred in 19 (25 %) symptomatic and 21 (20 %) asymptomatic children, at mean age 4.0 and 6.2 years, respectively (P = 0.084). In 16 (31 %) children with postnatally acquired CMV infection, CMV urinary excretion began at mean age 1.8 (range 0.3-7.3) years.
Both symptomatic and asymptomatic cCMV were associated with persistent long-term CMV excretion in urine, which was significantly longer in asymptomatic cCMV and not influenced by ganciclovir treatment in symptomatic cCMV. CMV urinary excretion was common in young children without cCMV, suggesting rapid CMV acquisition in childhood.
儿童巨细胞病毒(CMV)感染与尿液和唾液中病毒排泄时间延长有关。本研究对先天性(cCMV)和出生后获得性CMV感染儿童的CMV尿液排泄情况进行了特征描述。
对病毒学确诊的cCMV儿童(75例有症状,出生时105例无症状)和51例无cCMV儿童分别进行随访,随访时间中位数分别为11、18和17岁。在cCMV儿童中,CMV排泄持续时间定义为从首次阳性培养到最后一次阳性培养的不间断阳性结果,复发性CMV排泄定义为在1次以上阴性结果后出现≥1次阳性。无cCMV儿童的CMV尿液排泄定义为出生后获得性CMV感染所致。
有症状的cCMV儿童持续性CMV尿液排泄的平均持续时间为1.9(最长8.7)年,无症状儿童为2.8(最长9.8)年(P = 0.011)。17例接受更昔洛韦治疗的有症状儿童的CMV排泄平均持续时间(2.4年)与58例未治疗儿童(1.8年)相比,差异无统计学意义;P = 0.356。复发性排泄发生在19例(25%)有症状儿童和21例(20%)无症状儿童中,平均年龄分别为4.0岁和6.2岁(P = 0.084)。在16例(31%)出生后获得性CMV感染儿童中,CMV尿液排泄开始于平均年龄1.8(范围0.3 - 7.3)岁。
有症状和无症状的cCMV均与尿液中持续长期的CMV排泄有关,无症状cCMV的排泄时间明显更长,且有症状cCMV的排泄不受更昔洛韦治疗的影响。CMV尿液排泄在无cCMV的幼儿中很常见,提示儿童期CMV感染迅速。